MedTechVets Announces Veteran Placement Partnership with Insulet

MedTechVets, a nonprofit dedicated to helping military veterans transition into the medical technology industry, announces its Veteran Placement Partnership with Insulet Corporation (NASDAQ: PODD), a leader in tubeless insulin pump technology, whose mission is to improve the lives of people with diabetes and other conditions through its Omnipod^® delivery system. 

This collaboration aims to raise the bar on expanding career opportunities for veterans and fostering professional development in medical technology. Insulet will serve as key faculty for MedTechVets’ career prep programs, support mentorship initiatives, and expand networking opportunities to help veterans gain access to meaningful careers aligned with their skills and experiences.

“We are pleased to partner with MedTechVets to recruit top talent and leverage the unique skills of Veterans in the MedTech industry,” said Dan Manea, Insulet Chief Human Resources Officer. “We look forward to engaging with highly qualified and successful veterans who share a mission-driven mindset with our team to improve the lives for our customers.”

“MedTechVets is excited to work with Insulet, a leading global medical device company in diabetes management,” said Steve Mapa, MedTechVets’ President and Executive Director. “We are confident that our program graduates will adapt quickly to and thrive in their new mission and purpose to improve the lives of people with diabetes.”

This unique Veteran Placement Partnership embraces collaboration with both the Foundational and Executive Leadership Programs of MedTechVets. For more information, visit www.medtechvets.org

MedTechVets is a 501(c)(3) nonprofit organization dedicated to helping military veterans transition into successful careers in the medical technology industry. Through mentorship, networking opportunities, and educational resources, MedTechVets empowers veterans to leverage their unique skills and experiences in the service of advancing healthcare innovation. For more information, visit www.medtechvets.org.

Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the tubeless disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet’s flagship innovation, the Omnipod 5 Automated Insulin Delivery System, integrates with a continuous glucose monitor to manage blood sugar with no multiple daily injections, zero fingersticks, and can be controlled by a compatible personal smartphone in the U.S. or by the Omnipod 5 Controller. Insulet also leverages the unique design of its Pod by tailoring its Omnipod technology platform for the delivery of non-insulin subcutaneous drugs across other therapeutic areas. For more information, please visit insulet.com and omnipod.com.